24/01/2020
Mirrhia reaches the African Continent
Mirrhia has been selected to equip a brand new facility in Senegal dedicated to the production of the yellow fever vaccine.
Mirrhia will be deployed to monitor and ensure the quality of a yellow fever vaccine production line located in Dakar.
We are proud to accompany this institute in its efforts to fight this serious, potentially deadly disease.
Mirrhia distributed on the African Continent in such a large scale project is a major step in our international expansion.
Other News